Blocking androgen response could be key for halting tumor progression in prostate cancer
Wednesday, July 21st, 2010 Posted in hormone therapy | No Comments »Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth. Previous studies showed that prostate cancer advances when tumors become ...
How many early detected prostate cancers are needed to prevent one death?
Tuesday, July 20th, 2010 Posted in prostate cancer diagnosis | No Comments »A study at Hospital Clinico Universitario Zaragoza, Spain, aimed to determine the clinical significance of diagnosis and treatment of prostate cancer diagnosed in asymptomatic patients, in terms of survival and to face its disadvantages. The study conclusions highlight the limited evidence for ...
Lack of benefit for the ADT to dose-escalated RT in treatment of prostate cancer
Monday, July 19th, 2010 Posted in hormone therapy, radiation therapy | No Comments »Over the years, several randomized trials have shown the benefit of combining androgen deprivation therapy (ADT) with radiation therapy (RT) for the first- and second-line treatment of men with prostate cancer. A recent study at the William Beaumont Hospital in Michigan ...
There are options to fight prostate cancer
Sunday, July 18th, 2010 Posted in prostate cancer, prostate cancer risks | No Comments »Acording to American Cancer Society, by the age of 90, one in every six men will develop prostate cancer. Among common risk factors are mentioned age and the individual's race To fight prostate cancer, there are several treatment options including surgery, ...
UK: Minister confirms cancer treatment guarantee to be retained
Saturday, July 17th, 2010 Posted in prostate cancer | No Comments »The coalition government has confirmed it plans to retain a treatment guarantee for cancer patients introduced by Labour, after accusations that it was "ditching" the commitment. But Health Minister Simon Burns later intervened to confirm that the right to see a ...
Promise of new prostate cancer vaccine
Friday, July 16th, 2010 Posted in prostate cancer | No Comments »The first F.D.A approved prostate cancer vaccine is now available to patients and doctors say it's changing the way people can treat cancer. According to an officer Dana-Farber Cancer Institute it is not about vaccines in the sense of preventing a ...
How broccoli cuts prostate cancer risk
Thursday, July 15th, 2010 Posted in alternative treatments | No Comments »A new study has shed light on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers have found that sulforaphane, a chemical found in broccoli, interacts with cells lacking a gene called PTEN to reduce the chances of prostate ...
Claros Diagnostics receives CE Mark approval for point-of-care PSA system
Wednesday, July 14th, 2010 Posted in prostate cancer diagnosis | No Comments »Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform. This platform can now be used for prostate specific antigen (PSA) testing throughout the European Union. The ...
Follow-up data on cryotherapy for prostate cancer
Tuesday, July 13th, 2010 Posted in prostate cryotherapy | No Comments »In a newly published report, a team of clinicians from Columbia University Medical Center has provided data on the 10-year follow-up of a small group of patients treated with salvage or primary cryotherapy for prostate cancer. Clinicians claim that this ...
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49
Monday, July 12th, 2010 Posted in hormone therapy, radiation therapy | No Comments »A Phase II trial related to high-affinity antibody CC49 was investigated in 15 patients with hormone-resistant metastatic prostate cancer. Acientists found no acute adverse reactions occurred, but all patients had evidence of an immune response to CC49 by 4 weeks and concluded CC49 ...